In the current study, the chemosensitivity of pancreatic cancer cells to gemcitabine has been enhanced using a single and combination of ANGTPL4, Notch1 and NF-κβ1 siRNA. The gene discussed is NFKB1; the disease is familial pancreatic carcinoma.